Skip to Main Content

Advertisement

Skip Nav Destination

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

December 30, 2021
On location

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X